ClinicalTrials.gg
Status unknownNCT03013153Updated Jan 12, 2017

Low or High Ligation of the IMA With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery

An interventional study of Low ligation with apical lymph node dissection and High ligation in Rectal Cancer, sponsored by Sixth Affiliated Hospital, Sun Yat-sen University. Status unknown at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2017-01-12.

Sponsored by Sixth Affiliated Hospital, Sun Yat-sen University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
748
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery (IMA), protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. However, debate on the level of IMA ligation and debonding of splenic flexure never ends. This study is going to give a clear and definite answer to how and why surgeons should deal with the IMA in laparoscopy rectal surgery,base on the 3D reconstruction of IMA and identification of IMA perfusion types.

Read the detailed description

According to the report of World Health Organization 2015, the morbility and mortality of colorectal cancer (CRC) are rising all over the world. Although the technique gets great approval in CRC surgical treatment in the recent years, such as TME protocol, neoadjuvant and laparoscopy technique, the complication of anastomosis leakage and nerve damage are still to be solved.

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery, protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. However, debate on where is the best level of IMA ligation and whether splenic flexure be debonded never ends. This study is going to give a clear and definite answer to how and why surgeons should deal with the IMA in laparoscopy rectal surgery.

The ligation level of IMA affects on hypogastric and pelvic nerve, leads to disorder of sexual and urination functions. What's more, it also have affection on the apical lymph node (No.253) harvesting and the blood supplement of proximal colon. Former studies have proved that the blood supplement and tension of anastomosis leads to leakage after surgery. Meanwhile, the ligation level of IMA is the key point on it.

The former study comes from the sixth affiliated hospital found that the mistake of ligation level of IMA happened because of the poor touching and explosion with laparoscopy. The distance from the root of IMA to left colic artery (DRL) vary between 19mm and 64mm. When surgeon made mistake during ligation, it led to the insufficient resection of apical lymph node. Further more, affect the long-term survival. Besides, there are 4 different types of IMA according to the relationship between the left colic artery, sigmoid artery and superior rectal artery. These branches will confuse surgeon on how to deal with them. 3D reconstruction of abdominal pelvic CT is able to show the length of DRL, IMA types and apical lymph nodes clearly. With these technique, the investigators can preserve the left colic artery and resect apical lymph nodes precisely.

In the past studies, high or low ligation takes advantage on both side. But none of them comes from retrospective clinical trail. Some author believe that high ligation do better in resection of apical lymph nodes, release the tension of anastomosis, providing precise tumor staging. On the other side, some authors consider that high ligation may cut down blood supplement, rise the incident of anastomosis leakage (AL). so they prefer low ligation to the high. Some studies show that there are no long term survival difference between high and low ligation on IMA in laparoscopy rectal resection. So whether high ligation is necessary, still to be proved.

For local advanced rectal cancer, neoadjuvant chemotherapy can lesson tumor size, reduce recurrence, preserve annual better and rise long-term survival. National Comprehensive Cancer Network command chemotherapy before surgery (Total Mesorectal Excision TME) as the standard for rectal cancer since 2005. Another randomized controlled trial (RCT) named Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer (FOWARC) NCT01211210 has proved the recent positive result. In those cases, the positive metastasis apical lymph node appeared in less than 5% (5/116) cases. On the other side, the incident of AL was up to 7% (8/116) . This phenomenon discover that maybe low ligation with apical lymph nodes dissection can get the same treatment effect and decrease AL from happening.

02

Conditions studied

  • Rectal Cancer

Browse trials for

Keywords

  • Rectal Cancer
  • Inferior Mesenteric Artery
  • Ligation
  • Apical Lymph Nodes
  • Laparoscopy
  • IMA Types
03

In context

Rectal Neoplasms

1,804 studies on the registry are indexed under Rectal Neoplasms; 520 are open to participants now.

This study's planned enrollment of 748 is above the median of 66 across 1,330 interventional studies indexed under Rectal Neoplasms.

Browse Rectal Neoplasms studies →

Lead sponsor

Sixth Affiliated Hospital, Sun Yat-sen University is the lead sponsor of 217 studies on the registry; 111 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pathology shows rectal or sigmoid adenocarcinoma
  • The bottom edge of tumor to anuas is less than 15cm
  • The clinical staging of tumor by American Joint Committee on Cancer (AJCC) within T2-4 or N1-2
  • Receive or not receive neoadjuvant chemotherapy based on 5-fluorouracil before surgery
  • Racial resection in available after neoadjuvant chemotherapy
  • No metastasis evidence was found
  • Annual preservation surgery is available
  • Tolerate to general anesthesia
  • Eastern Cooperative Oncology Group (ECOG) status score between 0 and 1
  • Patients and general anesthesia can understand the clinical trail well and are willing to take part in

Exclusion criteria

Exclusion Criteria:

  • Suffer with other carcinoma synchronous or metachronous in 5 years
  • Multiple primary colon carcinoma
  • Radiation therapy was performed before surgery
  • History of colorectal surgery
  • Combine with acute intestinal obstruction, intestinal bleeding, intestinal perforation and emergency surgery is needed
  • Multiple organs resection surgery is needed
  • Abdominal perineal resection is performed
  • American Society of Anesthesiologists score stage IV to V
  • Pregnant, suckling period or reject to contraception
  • Severe cardiovascular disease, uncontrollable infection or other severe complication
  • Severe mental illness
  • Unable to go through the treatment because of family, society or regional condition
  • Refuse to take part in the trail
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
748 participants (estimated)

Study arms

  • Experimental
    Low ligation with apical lymph node dissection

    Left colic artery (LCA) is identified according to the CT 3D-reconstruction, tie the sigmoid artery and superior rectal artery, preserved LCA while low ligation of the inferior mesenteric artery is performed. Lymphadenectomy to the apical lymph nodes (No.253)is performed around the IMA until 2 cm from the aorta. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.

    Procedure: Low ligation with apical lymph node dissection

  • Active comparator
    High ligation

    Open the peritoneum proceeds cephalad towards the duodenojejunal angle of Treitz, and the mesenteric root is incised 1 cm below the inferior margin of the pancreas. The aortomesenteric window is opened wide and the inferior mesenteric vessels are exposed. The IMA is ligated and divided at 2 cm from its origin. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.

    Procedure: High ligation

Interventions

  • ProcedureLow ligation with apical lymph node dissection

    Low ligation with apical lymph node dissection (LAND). Left colic artery (LCA) is identified according to the CT 3D-reconstruction, tie the sigmoid artery and superior rectal artery, preserved LCA while low ligation of the inferior mesenteric artery is performed. Lymphadenectomy to the apical lymph nodes (No.253)is performed around the IMA until 2 cm from the aorta.

    Also known as: LAND

  • ProcedureHigh ligation

    High ligation (HL) Open the peritoneum proceeds cephalad towards the duodenojejunal angle of Treitz, and the mesenteric root is incised 1 cm below the inferior margin of the pancreas. The aortomesenteric window is opened wide and the inferior mesenteric vessels are exposed. The IMA is ligated and divided at 2 cm from its origin. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.

    Also known as: HL

06

What researchers measure

Primary outcomes

  1. 5-years overall survival rate

    5-years overall survival rate

    Time frame: 5 years

Secondary outcomes

  1. 5-years disease free survival rate

    5-years disease free survival rate

    Time frame: 5 years

  2. 1-year overall survival rate

    1-year overall survival rate

    Time frame: 1 year

  3. 1-year disease free survival rate

    1-year disease free survival rate

    Time frame: 1 year

  4. Anastomosis leakage rate

    anastomosis leakage rate after surgery, acute or chronic

    Time frame: 6 months

  5. Apical Lymph Nodes (LN) Positive Rate

    Apical Lymph Nodes Positive Rate, No.253 LN

    Time frame: 1 week

  6. Operation Time

    Time frame: 1 day

  7. Blood loss during operation

    Time frame: 1 day

  8. Complication incident rate of surgery

    Time frame: 1 day

  9. conversion rate to laparotomy

    Time frame: 1 day

  10. Identification of IMA perfusion type before surgery

    Time frame: 1 day

  11. Identification of lymph node metastasis by CT

    Time frame: 7 days

  12. Mortality rate in 30 days after surgery

    Time frame: 30 days

  13. Recovery time after surgery

    Time frame: 60 days

  14. White cell level

    Time frame: 7 days

  15. C-reaction protein level

    Time frame: 7 days

  16. Albumin level

    Time frame: 7 days

  17. Anastomosis bleeding rate after surgery

    Time frame: 30 days

  18. Anastomosis stenosis rate after surgery

    Time frame: 30 days

  19. Intestinal dysfunction after stoma closure

    Time frame: 1 year

  20. Anus function after surgery

    Time frame: 1 year

  21. Life quality scoring

    Time frame: 1 year

  22. Bladder residual urine volume

    Time frame: 1 year

  23. Sexual function scoring

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • The sixth affiliated hospital of Sun Yat-sen University
    Guangzhou, Guangdong 510655, China
    • Meijin Huang, MD · Contact · 13924073322@139.com · +8613924073322
    • Jiaming Zhou, MD · Contact · cysums03@163.com · +8613560031075
    • Jiaping Wang, MD · Principal investigator
    • Meijin Huang, MD · Principal investigator
    • Jiaming Zhou, MD · Sub investigator
    Recruiting
08

References and documents

Publications

  • Mari G, Maggioni D, Costanzi A, Miranda A, Rigamonti L, Crippa J, Magistro C, Di Lernia S, Forgione A, Carnevali P, Nichelatti M, Carzaniga P, Valenti F, Rovagnati M, Berselli M, Cocozza E, Livraghi L, Origi M, Scandroglio I, Roscio F, De Luca A, Ferrari G, Pugliese R. "High or low Inferior Mesenteric Artery ligation in Laparoscopic low Anterior Resection: study protocol for a randomized controlled trial" (HIGHLOW trial). Trials. 2015 Jan 27;16:21. doi: 10.1186/s13063-014-0537-5. PubMed 25623323 ↗
  • Bostrom P, Haapamaki MM, Matthiessen P, Ljung R, Rutegard J, Rutegard M. High arterial ligation and risk of anastomotic leakage in anterior resection for rectal cancer in patients with increased cardiovascular risk. Colorectal Dis. 2015 Nov;17(11):1018-27. doi: 10.1111/codi.12971. PubMed 25851151 ↗
  • Tanaka J, Nishikawa T, Tanaka T, Kiyomatsu T, Hata K, Kawai K, Kazama S, Nozawa H, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T. Analysis of anastomotic leakage after rectal surgery: A case-control study. Ann Med Surg (Lond). 2015 May 11;4(2):183-6. doi: 10.1016/j.amsu.2015.05.002. eCollection 2015 Jun. PubMed 26042185 ↗
  • Dauser B, Herbst F. Diagnosis, management and outcome of early anastomotic leakage following colorectal anastomosis using a compression device: is it different? Colorectal Dis. 2014 Dec;16(12):O435-9. doi: 10.1111/codi.12742. PubMed 25132419 ↗
  • GRIFFITHS JD. Surgical anatomy of the blood supply of the distal colon. Ann R Coll Surg Engl. 1956 Oct;19(4):241-56. No abstract available. PubMed 13363265 ↗
  • Masoni L, Mari FS, Nigri G, Favi F, Gasparrini M, Dall'Oglio A, Pindozzi F, Pancaldi A, Brescia A. Preservation of the inferior mesenteric artery via laparoscopic sigmoid colectomy performed for diverticular disease: real benefit or technical challenge: a randomized controlled clinical trial. Surg Endosc. 2013 Jan;27(1):199-206. doi: 10.1007/s00464-012-2420-3. Epub 2012 Jun 26. PubMed 22733197 ↗
  • Hida J, Okuno K. High ligation of the inferior mesenteric artery in rectal cancer surgery. Surg Today. 2013 Jan;43(1):8-19. doi: 10.1007/s00595-012-0359-6. Epub 2012 Oct 7. PubMed 23052748 ↗
  • Murono K, Kawai K, Kazama S, Ishihara S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T. Anatomy of the inferior mesenteric artery evaluated using 3-dimensional CT angiography. Dis Colon Rectum. 2015 Feb;58(2):214-9. doi: 10.1097/DCR.0000000000000285. PubMed 25585080 ↗
  • Seike K, Koda K, Saito N, Oda K, Kosugi C, Shimizu K, Miyazaki M. Laser Doppler assessment of the influence of division at the root of the inferior mesenteric artery on anastomotic blood flow in rectosigmoid cancer surgery. Int J Colorectal Dis. 2007 Jun;22(6):689-97. doi: 10.1007/s00384-006-0221-7. Epub 2006 Nov 3. PubMed 17082922 ↗
  • Battal B, Hamcan S, Akgun V, Bozkurt Y. Congenital superior-inferior mesenteric arterial variation or arc of Riolan due to occlusion of proximal superior mesenteric artery. Surg Radiol Anat. 2014 Apr;36(3):309-10. doi: 10.1007/s00276-013-1212-3. Epub 2013 Oct 18. No abstract available. PubMed 24135762 ↗
  • van Gulik TM, Schoots I. Anastomosis of Riolan revisited: the meandering mesenteric artery. Arch Surg. 2005 Dec;140(12):1225-9. doi: 10.1001/archsurg.140.12.1225. PubMed 16365247 ↗
  • Bertrand MM, Delmond L, Mazars R, Ripoche J, Macri F, Prudhomme M. Is low tie ligation truly reproducible in colorectal cancer surgery? Anatomical study of the inferior mesenteric artery division branches. Surg Radiol Anat. 2014 Dec;36(10):1057-62. doi: 10.1007/s00276-014-1281-y. Epub 2014 Mar 15. PubMed 24633578 ↗
  • Trencheva K, Morrissey KP, Wells M, Mancuso CA, Lee SW, Sonoda T, Michelassi F, Charlson ME, Milsom JW. Identifying important predictors for anastomotic leak after colon and rectal resection: prospective study on 616 patients. Ann Surg. 2013 Jan;257(1):108-13. doi: 10.1097/SLA.0b013e318262a6cd. PubMed 22968068 ↗
  • Hirst NA, Tiernan JP, Millner PA, Jayne DG. Systematic review of methods to predict and detect anastomotic leakage in colorectal surgery. Colorectal Dis. 2014 Feb;16(2):95-109. doi: 10.1111/codi.12411. PubMed 23992097 ↗
  • Silberhumer GR, Paty PB, Temple LK, Araujo RL, Denton B, Gonen M, Nash GM, Allen PJ, DeMatteo RP, Guillem J, Weiser MR, D'Angelica MI, Jarnagin WR, Wong DW, Fong Y. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg. 2015 Jun;209(6):935-42. doi: 10.1016/j.amjsurg.2014.09.024. Epub 2014 Dec 13. PubMed 25601556 ↗
  • Hadidi AT. A technique to improve vascularity in colon replacement of the esophagus. Eur J Pediatr Surg. 2006 Feb;16(1):39-44. doi: 10.1055/s-2006-923925. PubMed 16544225 ↗
  • Raboei EH, Luoma R. Colon patch esophagoplasty: an alternative to total esophagus replacement? Eur J Pediatr Surg. 2008 Aug;18(4):230-2. doi: 10.1055/s-2008-1038396. Epub 2008 Jul 15. PubMed 18629764 ↗
  • Cirocchi R, Trastulli S, Farinella E, Desiderio J, Vettoretto N, Parisi A, Boselli C, Noya G. High tie versus low tie of the inferior mesenteric artery in colorectal cancer: a RCT is needed. Surg Oncol. 2012 Sep;21(3):e111-23. doi: 10.1016/j.suronc.2012.04.004. Epub 2012 Jul 6. PubMed 22770982 ↗
  • Gervaz P, Platon A, Buchs NC, Rocher T, Perneger T, Poletti PA. CT scan-based modelling of anastomotic leak risk after colorectal surgery. Colorectal Dis. 2013;15(10):1295-300. doi: 10.1111/codi.12305. PubMed 23710555 ↗
  • Doeksen A, Tanis PJ, Wust AF, Vrouenraets BC, van Lanschot JJ, van Tets WF. Radiological evaluation of colorectal anastomoses. Int J Colorectal Dis. 2008 Sep;23(9):863-8. doi: 10.1007/s00384-008-0487-z. Epub 2008 Jun 17. PubMed 18560844 ↗
  • Hu X, Cheng Y. A Clinical Parameters-Based Model Predicts Anastomotic Leakage After a Laparoscopic Total Mesorectal Excision: A Large Study With Data From China. Medicine (Baltimore). 2015 Jul;94(26):e1003. doi: 10.1097/MD.0000000000001003. PubMed 26131798 ↗
  • Qu H, Liu Y, Bi DS. Clinical risk factors for anastomotic leakage after laparoscopic anterior resection for rectal cancer: a systematic review and meta-analysis. Surg Endosc. 2015 Dec;29(12):3608-17. doi: 10.1007/s00464-015-4117-x. Epub 2015 Mar 6. PubMed 25743996 ↗
  • Majbar MA, Elmalki Hadj O, Souadka A, El Alaoui M, Sabbah F, Raiss M, Hrora A, Ahallat M. Risk factors for anastomotic leakage after anterior resection for rectal adenocarcinoma. Tunis Med. 2014 Jul;92(7):493-6. PubMed 25775290 ↗

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2016, a primary completion of Dec 2018 and a completion of Dec 2023. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 31, 2016
First posted
Jan 6, 2017
Start
Dec 2016
Primary completionEst.
Dec 2018
CompletionEst.
Dec 2023
Last update
Jan 12, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03013153
Responsible party
Sponsor
First posted
Jan 6, 2017
Start date
Dec 2016
Primary completion
Dec 2018 (estimated)
Completion
Dec 2023 (estimated)
Last update
Jan 12, 2017

Study contacts

Jiaming Zhou, MD
Contact
cysums03@163.com
+8613560031075
Meijin Huang, MD
Contact
13924073322@139.com
+8613924073322
Meijin Huang, MD
study director · Sixth Affiliated Hospital, Sun Yat-sen University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion